We have two businesses: 

1)  Cannabis-based pharmaceuticals, and

2) Legacy infrastructure business. 

We are listed on the NYSE American: IGC
We are available for trading on the Borse Frankfurt: IGS1


Cannabis-based pharmaceuticals:



We are a leading cannabis pharmaceutical company with products aimed at improving the lives of patients battling Alzheimer’s disease, Parkinson’s disease, chronic pain, PTSD, and eating disorders.


Legacy infrastructure business

Based in India, Hong Kong, and Malaysia, our infrastructure business consists of commodity trading (steel, ore and building materials, among others), heavy construction equipment leasing, and real estate management.